Research News
See the video below to hear about the first retinal chip implant performed locally by a Mid Atlantic Retina surgeon.
Research
The specialists of Mid Atlantic Retina continue to be in the forefront with their research efforts and in the development of major innovations in retina care. Mid Atlantic Retina participates in several clinical trials investigating new forms of treatment for macular degeneration, diabetic retinopathy, and a variety of other retinal conditions.
Age-related Macular Degeneration (AMD) Studies
- Omega-3 Age-related Macular Degeneration Program
Sponsored by Lifeguard, Wills Eye Institute, and the Eye Research Institute
A Study of the Effects of Omega -3 Supplementation for Patients with Dry Age-related Macular Degeneration. - HARBOR Sponsored by Genentech
A Study of Ranibizumab Administered Monthly or on an As-Needed Basis in Patients With Subfoveal Neovascular Age-related Macular Degeneration. - FCFD4514S for Geographic Atrophy Sponsored by Genentech
A Study of the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of Intravitreal Injections of FCFD4514S in Patients With Geographic Atrophy. - AREDSII Sponsored by NEI
A Multi-Center, Randomized Trial of Lutein, Zeaxanthin and Omega-3 Long-Chain Polyunsaturated Fatty Acids (Docosahexaenoic Acid [DHA] and Eicosapentaenoic Acid [EPA]) in Age-related Macular Degeneration. - CABERNET Sponsored by Neo Vista
A Study of Strontium90 Beta Radiation With Lucentis to Treat Age-Related Macular Degeneration. - CATT Sponsored by NEI
Comparison of Age-Related Macular Degeneration Treatments Trials: Evaluating the Relative Efficacy and Safety of Treatment of Wet Age-related Macular Degeneration with Lucentis or Avastin. - HORIZON Sponsored by Genentech
An Extension Study to Evaluate the Safety and Tolerability of Lucentis for Wet Age-related Macular Degeneration or Macular Edema Due to Retinal Vein Occlusion. - RADICAL Sponsored by QLT, Inc.
A Study Comparing Combination Therapy with Reduced Fluence Visudyne (Photodynamic Therapy)-Lucentis-Dexamethasone Versus Lucentis Alone for Wet Age-related Macular Degeneration. - VIEW Sponsored by Regeneron
A Study of the Efficacy and Safety of Intravitreal VEGF Trap-Eye in Subjects With Wet Age-related Macular Degeneration
Uveitis Study
- Allergan Study Sponsored by Allergan
A Study of the Safety and Efficacy of a New Treatment for Non-Infectious Intermediate Uveitis.
Diabetic Retinopathy Studies
- ACCORD Sponsored by NHLBI and NEI
Examining the effect of various treatments on cardiovascular disease in people with diabetes. - Alimera Sponsored by Alimera Sciences
Fluocinolone Acetonide Implant Compared to Sham Injection in Patients With Diabetic Macular Edema. - RISE Sponsored by Genentech
A Study of Ranibizumab Injection in Subjects With Clinically Significant Macular Edema With Center Involvement Secondary to Diabetes Mellitus.
Central Retinal Vein Occlusion Studies
- VEGF Trap-Eye for CRVO Sponsored by Regeneron
A Study of the Efficacy, Safety, and Tolerability of Repeated Intravitreal Administration of Vascular Endothelial Growth Factor Trap-Eye in Subjects With Macular Edema Due to Central Retinal Vein Occlusion. - CRUISE Sponsored by Genentech
A Study of the Efficacy and Safety of Lucentis Injection in Patients With Macular Edema Secondary to Central Retinal Vein Occlusion.
Branch Retinal Vein Occlusion Study
- BRAVO Sponsored by Genentech
A Study of the Efficacy and Safety of Lucentis Injection in Patients With Macular Edema Secondary to Branch Retinal Vein Occlusion.
Retinitis Pigmentosa Study
- Argus™ II Retinal Stimulation System Feasibility Protocol Sponsored by Second Sight Medical Products
Evaluating the Safety and Utility of the Argus II Retinal Stimulation System in Providing Visual Function to Blind Subjects with Severe Retinitis Pigmentosa.
